Clinical Trials Browser

INDUSTRY × Melanoma × citarinostat × Clear all

NCT02935790 2017-08-24

Selective HDAC6 Inhibitor ACY-241 in Combination With Ipilimumab and Nivolumab

Phase 1 Completed

Melanoma